Venkataraman Balasubramanian

Array ( [id] => 9799807 [patent_doc_number] => 20150011751 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-08 [patent_title] => 'NOVEL TRIAZINE DERIVATIVE' [patent_app_type] => utility [patent_app_number] => 14/383860 [patent_app_country] => US [patent_app_date] => 2013-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 51961 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14383860 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9839594 [patent_doc_number] => 20150031676 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-29 [patent_title] => 'SUBSTITUTED BENZOTHIENYL-PYRROLOTRIAZINES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/380755 [patent_app_country] => US [patent_app_date] => 2013-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29228 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14380755 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11450276 [patent_doc_number] => 09573908 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-02-21 [patent_title] => 'Broad spectrum pro-quorum-sensing molecules as inhibitors of virulence in vibrios' [patent_app_type] => utility [patent_app_number] => 14/381432 [patent_app_country] => US [patent_app_date] => 2013-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 16 [patent_no_of_words] => 10747 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14381432 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8892468 [patent_doc_number] => 20130165651 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-27 [patent_title] => 'FUSED BICYCLIC mTOR INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/767947 [patent_app_country] => US [patent_app_date] => 2013-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 59294 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13767947 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9455467 [patent_doc_number] => 08716475 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-05-06 [patent_title] => '2-aminopyrimidine modulators of the histamine H4 receptor' [patent_app_type] => utility [patent_app_number] => 13/766375 [patent_app_country] => US [patent_app_date] => 2013-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33510 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13766375 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10402912 [patent_doc_number] => 20150287921 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-08 [patent_title] => 'AROMATIC AMINE DERIVATIVE, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE' [patent_app_type] => utility [patent_app_number] => 14/377784 [patent_app_country] => US [patent_app_date] => 2013-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15819 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14377784 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10096891 [patent_doc_number] => 09133192 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-15 [patent_title] => 'Piperidino-pyrimidine derivatives for the treatment of viral infections' [patent_app_type] => utility [patent_app_number] => 14/377064 [patent_app_country] => US [patent_app_date] => 2013-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10737 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14377064 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8866662 [patent_doc_number] => 20130150365 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-13 [patent_title] => 'Insecticidal Triazines and Pyrimidines' [patent_app_type] => utility [patent_app_number] => 13/760925 [patent_app_country] => US [patent_app_date] => 2013-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30651 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13760925 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8964157 [patent_doc_number] => 20130203758 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-08 [patent_title] => 'Compounds for the Treatment of Hepatitis C' [patent_app_type] => utility [patent_app_number] => 13/758624 [patent_app_country] => US [patent_app_date] => 2013-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27394 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13758624 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11230942 [patent_doc_number] => 09458162 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-10-04 [patent_title] => 'Cyclic molecules as bruton\'s tyrosine kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 14/375539 [patent_app_country] => US [patent_app_date] => 2013-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13690 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14375539 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9140345 [patent_doc_number] => 08580806 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-12 [patent_title] => 'Salts of 4-methyl N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide' [patent_app_type] => utility [patent_app_number] => 13/747052 [patent_app_country] => US [patent_app_date] => 2013-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8225 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13747052 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8884855 [patent_doc_number] => 20130158039 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-20 [patent_title] => 'N-((1R,2S,5R)-5-(TERT-BUTYLAMINO)-2-((S)-3-(7-TERT-BUTYLPYRAZOLO[1,5-A][1,3,5]TRIAZIN-4-YLAMINO)-2-OXOPYRROLIDIN-1-YL)CYCLOHEXYL)ACETAMIDE, A DUAL MODULATOR OF CHEMOKINE RECEPTOR ACTIVITY, CRYSTALLINE FORMS AND PROCESSES' [patent_app_type] => utility [patent_app_number] => 13/746389 [patent_app_country] => US [patent_app_date] => 2013-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 30751 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13746389 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10954617 [patent_doc_number] => 20140357637 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-04 [patent_title] => 'SUBSTITUTED ANNULATED PYRIMIDINES AND TRIAZINES, AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 14/371046 [patent_app_country] => US [patent_app_date] => 2013-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 55808 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14371046 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8854208 [patent_doc_number] => 20130143883 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-06 [patent_title] => 'MODULATORS FOR AMYLOID BETA' [patent_app_type] => utility [patent_app_number] => 13/733924 [patent_app_country] => US [patent_app_date] => 2013-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11909 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13733924 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10220561 [patent_doc_number] => 20150105555 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-16 [patent_title] => 'METHOD FOR SYNTHESIZING SAPROPTERIN DIHYDROCHLORIDE' [patent_app_type] => utility [patent_app_number] => 14/391712 [patent_app_country] => US [patent_app_date] => 2012-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12201 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14391712 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10234579 [patent_doc_number] => 20150119573 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-30 [patent_title] => 'METHOD FOR SYNTHESIZING SAPROPTERIN DIHYDROCHLORIDE' [patent_app_type] => utility [patent_app_number] => 14/394079 [patent_app_country] => US [patent_app_date] => 2012-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11591 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14394079 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10122502 [patent_doc_number] => 09156852 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-10-13 [patent_title] => 'Thieno[3,2-D]pyrimidine derivatives having inhibitory activity for protein kinases' [patent_app_type] => utility [patent_app_number] => 14/363857 [patent_app_country] => US [patent_app_date] => 2012-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39608 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14363857 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10090173 [patent_doc_number] => 09126986 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-08 [patent_title] => 'Hetero-bicyclic derivatives as HCV inhibitors' [patent_app_type] => utility [patent_app_number] => 14/368335 [patent_app_country] => US [patent_app_date] => 2012-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22725 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14368335 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11642124 [patent_doc_number] => 09663478 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-05-30 [patent_title] => 'Benzotriazine oxides as drugs targeting Mycobacterium tuberculosis' [patent_app_type] => utility [patent_app_number] => 13/726135 [patent_app_country] => US [patent_app_date] => 2012-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 21718 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13726135 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8940696 [patent_doc_number] => 20130190493 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-25 [patent_title] => 'Surface Modified Nanoparticles' [patent_app_type] => utility [patent_app_number] => 13/723418 [patent_app_country] => US [patent_app_date] => 2012-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6194 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13723418 [rel_patent_id] =>[rel_patent_doc_number] =>)